Atossa Genetics Stock Analysis

Atossa Stock Analysis Notes

About 19.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atossa Genetics recorded a loss per share of 0.23. The entity last dividend was issued on the 20th of April 2018. The firm had 1:12 split on the 20th of April 2018. Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. Atossa Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people. For more info on Atossa Genetics please contact FCAP MD at 206 588 0256 or go to https://www.atossatherapeutics.com.

Atossa Genetics Investment Alerts

Atossa Genetics Upcoming and Recent Events

Atossa Largest EPS Surprises

View All Earnings Estimates

Atossa Stock Institutional Investors

Note, although Atossa Genetics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Atossa Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.46 M.

Atossa Profitablity

Management Efficiency

Atossa Genetics has return on total asset (ROA) of (0.2987) % which means that it has lost $0.2987 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4889) %, meaning that it created substantial loss on money invested by shareholders. Atossa Genetics' management efficiency ratios could be used to measure how well Atossa Genetics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.32 in 2026. Return On Capital Employed is likely to drop to -0.37 in 2026. At this time, Atossa Genetics' Total Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 2.4 M in 2026, whereas Intangible Assets are likely to drop slightly above 11.4 K in 2026.

Technical Drivers

As of the 5th of January, Atossa Genetics shows the Standard Deviation of 4.34, mean deviation of 3.28, and Risk Adjusted Performance of (0.06). Atossa Genetics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Atossa Genetics variance and potential upside to decide if Atossa Genetics is priced correctly, providing market reflects its regular price of 0.62 per share. As Atossa Genetics is a penny stock we also strongly suggest to validate its jensen alpha numbers.

Atossa Genetics Price Movement Analysis

Atossa Genetics Insider Trading Activities

Atossa Genetics Outstanding Bonds

Atossa Genetics Predictive Daily Indicators

Atossa Genetics Forecast Models

Atossa Genetics' time-series forecasting models are one of many Atossa Genetics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Atossa Genetics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Atossa Genetics Bond Ratings

Atossa Genetics financial ratings play a critical role in determining how much Atossa Genetics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Atossa Genetics' borrowing costs.

Atossa Genetics Debt to Cash Allocation

Atossa Genetics currently holds 4.97 M in liabilities. Atossa Genetics has a current ratio of 34.49, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Atossa Genetics' use of debt, we should always consider it together with its cash and equity.

Atossa Genetics Total Assets Over Time

Atossa Genetics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Atossa Genetics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Atossa Genetics Debt Ratio

0.046

It appears most of the Atossa Genetics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Atossa Genetics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Atossa Genetics, which in turn will lower the firm's financial flexibility.

Atossa Genetics Corporate Bonds Issued

Atossa Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Atossa Genetics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Atossa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Atossa Genetics. By using and applying Atossa Stock analysis, traders can create a robust methodology for identifying Atossa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Atossa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Atossa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Atossa Genetics stock analysis indicators help investors evaluate how Atossa Genetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Atossa Genetics shares will generate the highest return on investment. By understating and applying Atossa Genetics stock analysis, traders can identify Atossa Genetics position entry and exit signals to maximize returns.

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.